[Effectiveness of capsules of the sodium salt of dicloxacillin in bronchopulmonary diseases].
Efficiency of sodium dicloxacillin in the form of capsules prepared at the All-Union Research Institute of Antibiotics was studied in treatment of 23 patients with acute pneumonia (mainly of staphylococcal etiology) and 16 patients with chronic pneumonia at the stage of exacerbation. High therapeutic effect of dicloxacillin in treatment of acute pneumonia in a daily dose of 4--5 gm was found. Satisfactory results were obtained with combined use of dicloxacillin and benzylpenicillin. In treatment of chronic pneumonia dicloxacillin was less effective. No toxic effect of dicloxacillin on the parenchymatose organs and peripheral blood was registered.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001996:Bronchopneumonia / Q000188:drug therapy*; D002214:Capsules; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004009:Dicloxacillin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008875:Middle Aged; D010400:Penicillin G / Q000627:therapeutic use; D011014:Pneumonia / Q000188:drug therapy
D002214:Capsules; D004009:Dicloxacillin; D010400:Penicillin G
Effektivnost' kapsul dikloksatsillina natrievoĭ soli pri bronkho-legochnykh zabolevaniiakh